Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Canis

Showing results (171-180 of 193) with videos related to

Pageof 20
Sort By:
European Journal of Cancer (Oxford, England : 1990)|October 3, 2022
DeepClassPathway: Molecular pathway aware classification using explainable deep learningElia Lombardo, Julia Hess, Christopher Kurz, et al.
Stroke|October 9, 2010
Tumor necrosis factor-α enhances microvascular tone and reduces blood flow in the cochlea via enhanced sphingosine-1-phosphate signalingElias Q Scherer, Jingli Yang, Martin Canis, et al.
Journal for Immunotherapy of Cancer|December 8, 2021
Uncoupled biological and chronological aging of neutrophils in cancer promotes tumor progressionLaura A Mittmann, Florian Haring, Johanna B Schaubächer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 21, 2024
Impact of <sup>18</sup>F-FDG PET Intensity Normalization on Radiomic Features of Oropharyngeal Squamous Cell Carcinomas and Machine Learning-Generated BiomarkersStefan P Haider, Tal Zeevi, Kariem Sharaf, et al.
Plos Biology|September 28, 2018
EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancersMin Pan, Henrik Schinke, Elke Luxenburger, et al.
BMC Cancer|May 24, 2026
Targeting EpCAM expression via near-infrared fluorescent antibodies enables microscopic delineation of primary and recurrent HNSCCBernd Uhl, Dennis Eggert, Bojan Smiljanov, et al.
AJNR. American Journal of Neuroradiology|May 16, 2025
FDG-PET intensity normalization improves radiomics- based survival prediction in oropharyngeal cancer patients: a comparison of the SUV with alternative normalization techniquesSeyedmehdi Payabvash, Kariem Sharaf, Tal Zeevi, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2025
Durable response to nivolumab in combination with regional hyperthermia in a patient with PD-L1-negative metastatic head and neck squamous cell carcinomaLuc M Berclaz, Anton Burkhard-Meier, Axel Lechner, et al.
NPJ Precision Oncology|February 3, 2026
Personalized ctDNA analysis for detection of residual disease and recurrence in surgically treated HNSCC patientsSusanne Flach, Christodoulos Pipinikas, Tom Huberty, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|June 1, 2026
Disease-specificity in correlations between speech audiometry, hearing-related quality of life, and varying calculation methods for pure tone average in middle ear diseasesIvo Grueninger, Julia van de Loo, Sara Alekuzei, et al.
Pageof 20

Showing results (171-180 of 193) with videos related to

Sort By:
Pageof 20
European Journal of Cancer (Oxford, England : 1990)|October 3, 2022
DeepClassPathway: Molecular pathway aware classification using explainable deep learningElia Lombardo, Julia Hess, Christopher Kurz, et al.
Stroke|October 9, 2010
Tumor necrosis factor-α enhances microvascular tone and reduces blood flow in the cochlea via enhanced sphingosine-1-phosphate signalingElias Q Scherer, Jingli Yang, Martin Canis, et al.
Journal for Immunotherapy of Cancer|December 8, 2021
Uncoupled biological and chronological aging of neutrophils in cancer promotes tumor progressionLaura A Mittmann, Florian Haring, Johanna B Schaubächer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 21, 2024
Impact of <sup>18</sup>F-FDG PET Intensity Normalization on Radiomic Features of Oropharyngeal Squamous Cell Carcinomas and Machine Learning-Generated BiomarkersStefan P Haider, Tal Zeevi, Kariem Sharaf, et al.
Plos Biology|September 28, 2018
EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancersMin Pan, Henrik Schinke, Elke Luxenburger, et al.
BMC Cancer|May 24, 2026
Targeting EpCAM expression via near-infrared fluorescent antibodies enables microscopic delineation of primary and recurrent HNSCCBernd Uhl, Dennis Eggert, Bojan Smiljanov, et al.
AJNR. American Journal of Neuroradiology|May 16, 2025
FDG-PET intensity normalization improves radiomics- based survival prediction in oropharyngeal cancer patients: a comparison of the SUV with alternative normalization techniquesSeyedmehdi Payabvash, Kariem Sharaf, Tal Zeevi, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2025
Durable response to nivolumab in combination with regional hyperthermia in a patient with PD-L1-negative metastatic head and neck squamous cell carcinomaLuc M Berclaz, Anton Burkhard-Meier, Axel Lechner, et al.
NPJ Precision Oncology|February 3, 2026
Personalized ctDNA analysis for detection of residual disease and recurrence in surgically treated HNSCC patientsSusanne Flach, Christodoulos Pipinikas, Tom Huberty, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|June 1, 2026
Disease-specificity in correlations between speech audiometry, hearing-related quality of life, and varying calculation methods for pure tone average in middle ear diseasesIvo Grueninger, Julia van de Loo, Sara Alekuzei, et al.
Pageof 20